CEO Message

Pursuing TSUMURA VISION "Cho-WA" 2031 for Creating a Future of Harmony

President and Representative Director, CEO

We would like to express our heartfelt gratitude to our sincere gratitude for their continued support.

In the fiscal year 2024, we faced a challenging external environment characterized by rising prices due to inflation and foreign exchange fluctuations. On the other hand, during the same fiscal year, our Kampo medicine prices were raised due to a special measure aimed at ensuring the stable supply of items deemed essential for healthcare, following the re-evaluation of unprofitable products during the drug price revision. Despite these circumstances, we achieved the target figures for consolidated sales, operating profit, and ROE set forth in our first medium-term management plan. We will continue to invest in strengthening our stable supply system to ensure that patients can receive our Kampo medicines consistently.

The fiscal year 2025 marks an important year as we launch the second medium-term management plan (2025-2027) aimed at realizing the "TSUMURA VISION 'Cho-WA' 2031." We will set milestones through back casting and work collectively across the group to achieve our goals.

The Tsumura Group, with our corporate purpose of "Lively Living for Everyone," aims to create value through pharmaceuticals and products derived from natural sources. We strive for sustainable and stable supply by ensuring high-quality raw material crude dugs procurement and consistent manufacturing and sales of our Kampo medicines. We are committed to contributing to healthcare without leaving anyone behind.

For our group, which has grown by scientifically understanding the wisdom of nature, engaging in the creation of shared values rooted in a sustainable society and natural environment is seen to enhance our competitive advantage and contribute to increasing corporate value. We kindly ask you for your continued support.